Author
Listed:
- Felix Wong
(Broad Institute of MIT and Harvard
Massachusetts Institute of Technology
Integrated Biosciences)
- Erica J. Zheng
(Broad Institute of MIT and Harvard
Harvard University
Harvard University)
- Jacqueline A. Valeri
(Broad Institute of MIT and Harvard
Massachusetts Institute of Technology
Harvard University)
- Nina M. Donghia
(Harvard University)
- Melis N. Anahtar
(Broad Institute of MIT and Harvard)
- Satotaka Omori
(Broad Institute of MIT and Harvard
Integrated Biosciences)
- Alicia Li
(Integrated Biosciences)
- Andres Cubillos-Ruiz
(Broad Institute of MIT and Harvard
Massachusetts Institute of Technology
Harvard University)
- Aarti Krishnan
(Broad Institute of MIT and Harvard
Massachusetts Institute of Technology)
- Wengong Jin
(Broad Institute of MIT and Harvard)
- Abigail L. Manson
(Broad Institute of MIT and Harvard)
- Jens Friedrichs
(Leibniz Institute of Polymer Research and the Max Bergmann Center of Biomaterials)
- Ralf Helbig
(Leibniz Institute of Polymer Research and the Max Bergmann Center of Biomaterials)
- Behnoush Hajian
(Center for the Development of Therapeutics, Broad Institute of MIT and Harvard)
- Dawid K. Fiejtek
(Center for the Development of Therapeutics, Broad Institute of MIT and Harvard)
- Florence F. Wagner
(Center for the Development of Therapeutics, Broad Institute of MIT and Harvard)
- Holly H. Soutter
(Center for the Development of Therapeutics, Broad Institute of MIT and Harvard)
- Ashlee M. Earl
(Broad Institute of MIT and Harvard)
- Jonathan M. Stokes
(Broad Institute of MIT and Harvard
Massachusetts Institute of Technology
McMaster University)
- Lars D. Renner
(Leibniz Institute of Polymer Research and the Max Bergmann Center of Biomaterials)
- James J. Collins
(Broad Institute of MIT and Harvard
Massachusetts Institute of Technology
Harvard University)
Abstract
The discovery of novel structural classes of antibiotics is urgently needed to address the ongoing antibiotic resistance crisis1–9. Deep learning approaches have aided in exploring chemical spaces1,10–15; these typically use black box models and do not provide chemical insights. Here we reasoned that the chemical substructures associated with antibiotic activity learned by neural network models can be identified and used to predict structural classes of antibiotics. We tested this hypothesis by developing an explainable, substructure-based approach for the efficient, deep learning-guided exploration of chemical spaces. We determined the antibiotic activities and human cell cytotoxicity profiles of 39,312 compounds and applied ensembles of graph neural networks to predict antibiotic activity and cytotoxicity for 12,076,365 compounds. Using explainable graph algorithms, we identified substructure-based rationales for compounds with high predicted antibiotic activity and low predicted cytotoxicity. We empirically tested 283 compounds and found that compounds exhibiting antibiotic activity against Staphylococcus aureus were enriched in putative structural classes arising from rationales. Of these structural classes of compounds, one is selective against methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci, evades substantial resistance, and reduces bacterial titres in mouse models of MRSA skin and systemic thigh infection. Our approach enables the deep learning-guided discovery of structural classes of antibiotics and demonstrates that machine learning models in drug discovery can be explainable, providing insights into the chemical substructures that underlie selective antibiotic activity.
Suggested Citation
Felix Wong & Erica J. Zheng & Jacqueline A. Valeri & Nina M. Donghia & Melis N. Anahtar & Satotaka Omori & Alicia Li & Andres Cubillos-Ruiz & Aarti Krishnan & Wengong Jin & Abigail L. Manson & Jens Fr, 2024.
"Discovery of a structural class of antibiotics with explainable deep learning,"
Nature, Nature, vol. 626(7997), pages 177-185, February.
Handle:
RePEc:nat:nature:v:626:y:2024:i:7997:d:10.1038_s41586-023-06887-8
DOI: 10.1038/s41586-023-06887-8
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:626:y:2024:i:7997:d:10.1038_s41586-023-06887-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.